Human respiratory syncytial virus (RSV) and Sendai virus (SeV) are enveloped, negative-strand RNA viruses that belong to the Pneumovirinae and Paramyxovirinae subfamilies, respectively, of the Paramyxoviridae (6) . Cell entry by paramyxoviruses requires virus binding to target cell receptors, followed by fusion of the viral envelope with the cellular plasma membrane. Cells infected by paramyxoviruses may also fuse with adjacent cells to form syncytia (multinucleated cells). Both virus-cell and cell-cell fusion processes are mediated by the viral fusion (F) protein, a trimeric type I integral membrane glycoprotein.
For members of the Paramyxovirinae, including SeV, fusion mediated by the F glycoprotein requires participation of the homologous attachment protein (glycoprotein [G], hemagglutinin [H], or hemagglutinin-neuraminidase [HN] ). It has been hypothesized that conformational changes occurring in the attachment protein following binding to target cell receptors are transduced to the F protein to activate it for fusion "at the right time and in the right place" (26) (27) (28) . Sialic acid-containing gangliosides act as the cellular receptor for the Sendai virus HN attachment protein (31, 32) . While the specific cell surface receptor for pneumoviruses is unknown, RSV has been shown to interact with cell surface glycosaminoglycans (GAGs), in particular, with heparan sulfate (12, 13, 18, 20, 25, 33) . Furthermore, the fusion protein of both human and bovine RSV (BRSV), as well as human metapneumovirus (MPV) is sufficient to mediate attachment and fusion in the absence of the G attachment protein (2, 16, 21, 43, 44, 47, 48, 52) . Thus, the role of pneumovirus attachment proteins in triggering fusion is currently unclear. Since RSV F protein (F RSV ) also binds to GAGs, the interaction between F RSV and heparan sulfate on the target cell surface may mediate virus attachment in the absence of the G protein (14, 20, 48) .
The paramyxovirus F protein is synthesized as an inactive precursor (F 0 ), which is cleaved at a mono-or multibasic cleavage site by cellular proteases to produce a fusion-competent, disulfide-linked F 2 -F 1 complex (for a review, see reference 28) . Cleavage is an absolute requirement for fusion since the newly formed F 1 N terminus contains a hydrophobic fusion peptide that is inserted into the cell membrane during fusion (40) . Furthermore, the nature of the cleavage motif is a major determinant of virus pathogenicity (23) . Sendai virus F protein (F SeV ) is cleaved at a monobasic cleavage site (R116) and thus requires the addition of trypsin to fuse cells in culture (22, 42) . In contrast, RSV F protein (F RSV ) possesses two conserved multibasic furin-dependent cleavage sites (site I, RARR109; site II, KKRKRR136), separated by a region of 27 amino acids (pep27). The presence of two cleavage sites in F RSV is unique among paramyxoviruses although two cleavage sites have been observed in the severe acute respiratory syndrome (SARS) coronavirus spike protein (1) . Interestingly, while cell-cell fusion directed by F RSV does not depend on coexpression of an attachment protein, there is a requirement for proteolytic processing at both cleavage sites, accompanied by removal of the intervening pep27, which is secreted into the culture medium (16, 39, 52) . Furthermore, completion of cleavage at both sites is associated with a change in shape of the RSV F protein (34, 39) . However, while double cleavage of F RSV is an essential requirement for cell-cell fusion, its role in infection is less clear. For instance, recombinant bovine RSV (rBRSV) expressing F protein with an intact cleavage site II, but lacking both site I and the intervening pep27, replicated with kinetics similar to that of the parental virus, despite displaying drastically reduced syncytium formation (53) .
We have previously constructed a series of plasmids encoding chimeric F SeV mutants by inserting one or both F RSV cleavage sites and various regions of pep27 into F SeV (38) . Inclusion of both F RSV cleavage sites in F SeV resulted in a dramatic increase in fusion of transfected cells, as well as a decreased dependency on the HN protein for cell-cell fusion. It was hypothesized that the presence of two multibasic cleavage sites might represent a strategy to activate the RSV F protein for cell-cell fusion in the absence of an attachment protein. However, mutations found to destabilize the envelope (Env) glycoprotein of murine leukemia virus (MLV) and enhance syncytium formation in transfected cells were found to be detrimental for viral growth (29) . The explanation offered for these findings was that unstable Env proteins at the cell membrane are continuously replaced by new molecules, which are able to mediate cell-cell fusion. In contrast, such unstable proteins may be prematurely activated in the virus particle before virus-cell contact takes place, thereby inactivating the virus. Moreover, it has been suggested that cell-cell and virus-cell fusion processes have different structural requirements (7) .
Therefore, as a natural continuation of our previous work, it was of interest to generate recombinant Sendai viruses (rSeV) that express mutant F proteins containing one or both F RSV cleavage sites, separated by either a partial or complete intervening pep27 sequence. We found that rSeV expressing cleavage site F protein mutants displayed reduced thermostability compared to wild-type (wt) rSeV. Moreover, rSeV expressing F protein containing both F RSV cleavage sites displayed enhanced cell-to-cell fusion and a decreased dependency on receptor recognition for viral infection. Therefore, insertion of the double F RSV cleavage sites in F SeV in the context of rSeV reproduced the ability of RSV to infect cells in the absence of an attachment protein. The RSV F protein double cleavage sites may thus represent an alternative mechanism to regulate fusion, which is independent of the viral attachment protein.
MATERIALS AND METHODS
Cell lines. BSR-T7/5 (4) (a gift from K.-K. Conzelmann, Munich, Germany) and LLC-MK2 cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Bio Whittaker), supplemented with 10% fetal calf serum (FCS). Alternate passages of BSR-T7/5 cells were supplemented with 1 mg/ml G418 sulfate (Sigma) in order to select for T7 polymerase expression. CHO cell derivatives (45), Pro-5 (ATCC CRL-1781), and sialic acid-deficient Lec-2 cells (ATCC CRL-1736) were obtained from the American Type Culture Collection and maintained in alpha minimum essential medium (Sigma) supplemented with 10% FCS.
Plasmids and mutagenesis. Construction of the pTM1 plasmids encoding Sendai virus F protein (F SeV ) cleavage site mutants detailed in Fig. 1 has been described previously (38 Fig. 1]) were subcloned from pTM1 into the FL5 plasmid. FL5 is an 18.3-kb plasmid that contains the full-length SeV cDNA (Z strain) and MluI and RsrII unique restriction sites, which flank the F gene. Sendai virus F genes were initially amplified from pTM1 plasmids by PCR using the following oligonucleotides containing MluI and RsrII restriction sites (italicized): AACTTAGGGATAAAGTCCCTTGTGAACGCGTGGTTGCAA AACTCTCCCCTTGGGAAACATGACAGCATATATCCAGAGGTCACA GTGC (positive sense) and TAAGTTTTTCTTATTATATACAGATCGGACC GAATACCATGCCTGCTTTACAAGACATCTGATAATGGTCGTGAAGTT CATCGTTTCTCAGCCATCGCATCAAACC (negative sense). According to the "rule of six," replication of the SeV genome occurs efficiently only when the genome is an exact multiple of six nucleotides (5) . Thus, on replacement of the wild type F SeV gene with the cleavage site mutants, insertion of 3 nucleotides in the noncoding region of SeV (shown in bold) was required to ensure that the length of SeV remained a multiple of six. The resulting PCR products were digested with MluI and RsrII enzymes (Roche) and subcloned into plasmid FL5 in order to replace the wild-type SeV F gene (Z strain) present in FL5.
Recovery of recombinant Sendai virus. BSR-T7/5 cells that constitutively express T7 polymerase were cotransfected using FuGENE HD (Roche) with FL5 plasmids containing either wild-type F H or cleavage site F mutants, along with three pTM1 plasmids expressing the nucleoprotein (N), phosphoprotein (P), and large RNA-dependent RNA polymerase (L) proteins under transcriptional control of the T7 promoter. At 24 h posttransfection, cells were washed with serumfree DMEM, and 0.5 g/ml trypsin was added to the culture medium. Cells were incubated for a further 24 h at 33°C to allow virus growth, and fresh trypsin was added at 48 h posttransfection. Cells were collected at 72 h posttransfection and injected into 9-day-old embryonated chicken eggs, which permit the growth of SeV to high titers (15) . Following incubation for 48 h at 34°C, allantoic fluid was collected and clarified by low-speed centrifugation. In order to confirm virus rescue, allantoic fluid was pelleted through a 25% glycerol cushion for 30 min at 15,000 rpm and loaded onto a 10% SDS-PAGE gel to detect viral proteins. Alternatively, clarified allantoic fluid was purified through a 4-ml 20% sucrose cushion in Beckman SW28 tubes by centrifugation for 2 h at 26,000 rpm, as previously described (30) .
Virus titration and growth kinetics. In order to follow replication of SeV over multiple replication cycles, LLC-MK2 cells in six-well plates were inoculated with rSeV at a multiplicity of infection (MOI) of 0.05 and incubated at 37°C for 2 h in DMEM containing 2.5% fetal calf serum (DMEM-2.5% FCS). Following adsorption, cells were washed and incubated at 33°C or 37°C for a further 96 h in serum-free DMEM with or without 0.3 g/ml trypsin. Aliquots of cell culture supernatant (500 l) were taken at 24-h intervals and replaced with fresh medium with or without trypsin. Viruses were subsequently titrated in duplicate by the method of Borisevich et al. (3) . Briefly, LLC-MK2 cells in 96-well plates were infected with serial dilutions of virus in DMEM-2.5% FCS. Cells were incubated at 37°C for 2 h, washed in serum-free DMEM, and incubated in serum-free medium supplemented with 0.3 g/ml trypsin. At 18 h postinfection, cells were washed with phosphate-buffered saline (PBS) containing 1% bovine serum albumin (PBS-1% BSA) and fixed for 30 min at 4°C with methanol containing 2% H 2 O 2 . Fixed cells were blocked with PBS-1% BSA and stained for expression of SeV F protein with monoclonal antibody (MAb) GB5 (a gift from S. Wharton and J. J Skehel, London, United Kingdom) for 1 h at room temperature, followed by incubation with anti-mouse immunoglobulin conjugated to horseradish peroxidase (Amersham Biosciences UK Ltd.) for 30 min at room temperature. The resulting immune complexes were developed using the substrate 3-amino-9-ethylcarbazole (AEC; Sigma) dissolved in dimethyl sulfoxide (DMSO; 3.3 mg/ml), 0.1 M citrate, 0.2 M phosphate, pH 5.5, and 0.06% H 2 O 2 . Immunostained (red) cells were counted using a light microscope.
Western blotting. Proteins separated on a 10% SDS-PAGE gel were transferred to an Immobilon membrane (Millipore) and subjected to Western blotting using polyclonal rabbit serum raised against amino acids 104 to 117 of RSV F protein [F RSV (104-117)] (16) or the cytoplasmic tail of SeV F protein [F SeV (CT)] (a gift from L. Roux, Geneva, Switzerland). Membranes were subsequently incubated with anti-mouse immunoglobulin conjugated to peroxidase. Bands were visualized using an Amersham ECL Advance Western Blotting Detection Kit (GE Healthcare UK, Ltd.) and imaged using a Kodak Gel Logic 1500 Imaging System camera and Kodak Molecular Imaging software. The net intensity of protein bands indicated in the legend to Fig. 3 was measured using Kodak Molecular Imaging software, and the percentage of F protein cleavage to F 1 was calculated by dividing the intensity of F 1 bands by the total net intensity.
Hemolysis. Purified SeV (5 ϫ 10 8 focus-forming units [FFU] ) was incubated at 33°C for 45 min with 0.5 ml of washed guinea pig erythrocytes (1%, vol/vol, in PBS). Hemolysis was measured by determining the optical density of the erythrocyte supernatant at 520 nm.
Immunofluorescence. Infected LLC-MK2 or CHO cells growing in microchamber culture slides in the absence or presence of 0.3 g/ml trypsin were fixed with cold (Ϫ20°C) methanol for 5 min, followed by cold acetone for 30 s. Fixed cells were subsequently immunostained using MAb GB5 directed against F SeV , followed by incubation with anti-mouse fluorescein-linked antibody (GE Healthcare UK, Ltd.). Cells were examined using a Zeiss microscope and photographed using an AxioCam HRc digital camera and Axiovision, version 3.1, software. The sizes of syncytia for LLC-MK2 cells were measured by counting the number of nuclei in 10 syncytia selected at random from distinct ϫ20 magnification fields. For the experiment shown in Fig. 7 , LLC-MK2 cells in monolayers were pretreated prior to infection with 120 mU of neuraminidase (NA) from Clostridium perfringens (Sigma) in OptiMEM medium (Gibco) for 90 min at 37°C. The level of infection in the absence or presence of neuraminidase was determined by counting the number of infected cells in five ϫ20 magnification fields selected at random.
Luciferase reporter gene cell-cell fusion assay. BSR-T7/5 cells were infected in DMEM-2.5% FCS at an MOI of 5 and incubated at 37°C for 2 h. BSR-T7/5 cells were subsequently washed in serum-free DMEM and incubated for 14 h in serum-free medium supplemented with or without 0.25 g/ml trypsin. LLC-MK2 cells in 100-cm dishes were transfected (FuGENE HD; Roche) with 30 g of a plasmid encoding the luciferase gene (pTM1-Luc) and incubated at 37°C for 14 h in DMEM-2.5% FCS. For the cell-cell fusion assay, LLC-MK2 cells were detached 14 h posttransfection using 1 mM EDTA in Ca 2ϩ -and Mg 2ϩ -free PBS, resuspended at a density of 1 ϫ 10 6 cells/ml in serum-free medium, and overlaid at a 1:1 ratio onto BSR-T7/5 cells, either in the presence or absence of 0.25 g/ml trypsin (Sigma). The mixed donor and target cells were incubated for 3 h at 33°C or 37°C to allow fusion. Cells were subsequently washed with PBS and lysed in 1ϫ passive lysis buffer (Promega Inc.), according to the manufacturer's instructions. Ten microliters of clarified cell extract was mixed with 100 l of luciferase assay substrate (Promega Inc.) and assayed for luciferase activity over a 10-s measurement read using a Turner Biosystems 20/20n Luminometer instrument.
Enzyme-linked immunosorbent assay (ELISA). Infected Pro-5 or Lec-2 cells (MOI of 1) growing in 96-well microtiter plates were washed at 20 h postinfection with PBS containing 0.05% Tween 20 (Bio-Rad Laboratories) (PBS-Tween) and fixed in 80% acetone. The wells were blocked for 30 min at room temperature with 5% pig serum in 0.05% PBS-Tween. Cells were subsequently stained for expression of SeV F protein with MAb GB5 for 1 h at room temperature, followed by incubation with anti-mouse immunoglobulin conjugated to horseradish peroxidase (Amersham Biosciences UK, Ltd.) for 45 min at room temperature. The optical density at 490 nm was measured after the addition of the substrate O-phenyl-diamine (OPD), dissolved in a buffer containing 0.1 M citrate, 0.2 M phosphate, pH 5.5, and 0.06% H 2 O 2 .
RESULTS
Generation and expression of recombinant Sendai viruses containing mutations at the fusion protein cleavage site. Recombinant Sendai viruses (rSeV) containing F SeV cleavage site mutations were generated from a cDNA clone (FL5). FL5 is an 18.3-kb plasmid that contains the full-length SeV cDNA (Z strain) and various unique restriction enzyme sites. The genes encoding wild-type SeV F from the Harris strain (F H ) and SeV cleavage mutants Fc, F117, and F130 (38) (Fig. 1A) were subcloned into the FL5 plasmid between MluI and RsrII restriction sites, replacing the wild-type SeV F gene (Z strain) present in FL5.
BSR-T7/5 cells that constitutively express T7 RNA polymerase were cotransfected with FL5 cDNA and pTM1 plasmids encoding the nucleoprotein (N), the phosphoprotein (P), and the large RNA-dependent RNA polymerase (L) proteins under transcriptional control of the T7 promoter. Transfected BSR-T7/5 cells were incubated in the absence or presence of trypsin at 33°C for 72 h, and the cell culture supernatant was subsequently passaged in 9-day-old embryonated chicken eggs to increase viral yield (15) . In order to detect the presence of viral proteins, allantoic fluid was pelleted through a 25% glycerol cushion for 30 min at 15,000 rpm and loaded onto a 10% SDS-PAGE gel. As seen in Fig. 1B , all SeV recombinants (SeV-F H , SeV-Fc, SeV-F117, and SeV-F130) were successfully rescued. Titration of the allantoic fluid by the method of Borisevich et al. (3) revealed that double-cleavage-site mutants SeV-F117 and SeV-F130 were attained at lower titers than single-cleavage-site mutants SeV-FH and SeV-Fc, as detailed in the legend of Fig. 1B . Whether these differences reflect lower replication or lower efficiency of rescue of the doublecleavage-site viruses compared with single-cleavage-site viruses is not known at present. The band representing the M protein appears fainter, and additional bands are present for the double-cleavage-site mutant proteins, in particular, for F117. This may reflect degradation of purified virus on SDS-PAGE sample preparation or the presence of contaminating bands from the allantoic fluid on virus purification. Sequencing of RT-PCR products confirmed that the F and HN genes had not acquired spurious mutations during the rescue (data not shown).
F protein expression by rSeV was confirmed by Western blotting with a polyclonal serum directed against the cytoplasmic tail (CT) of F SeV (Fig. 1C) . Faint bands migrating with a size corresponding to F 0 were observed only for single-cleavage-site F H and Fc mutants, suggesting that almost complete cleavage of the F proteins to F 1 had taken place. It is likely that trypsin-like endoproteases present in embryonated chicken eggs are responsible for cleavage of the F protein (17, 35) .
Multicycle replication of recombinant Sendai viruses. LLC-MK2 cells were infected with the rSeV at a low multiplicity of infection (MOI) of 0.05 and incubated in the absence or presence of trypsin for 96 h. At 24-h intervals, aliquots of cell culture supernatant were taken and replaced with fresh medium, with or without trypsin. Titration of the culture supernatant was performed by immunohistochemical staining of infected LLC-MK2 cell foci in 96-well plates (3). As can be seen from Fig. 2 , wt SeV-F H virus required the presence of trypsin in order to replicate, consistent with previously published findings that SeV requires trypsin for F protein cleavage (42) . In contrast, all of the F protein cleavage mutant strains replicated to high titers in both the absence and presence of trypsin although viruses grew to higher titers (at least one logarithm) in the presence of trypsin (Fig. 2B) . While all of the mutants reached titers comparable to the titer of wt SeV-F H at 96 h postinfection, the double-cleavage-site mutants displayed slightly faster replication kinetics during the first 48 h of infection. This difference in replication kinetics was further enhanced when virus was grown at 33°C, with double-cleavage-site mutants replicating to titers approximately 1 logarithm higher than single-cleavagesite viruses during the first 48 h of infection (Table 1) . Therefore, insertion of both F RSV cleavage sites in SeV F protein leads to faster replication kinetics in LLC-MK2 cells during the first 48 h of replication, in particular at 33°C, but does not alter the overall titers obtained after 96 h.
Proteolytic cleavage of recombinant Sendai viruses. The extent of proteolytic cleavage of mutant F proteins from virus present in cell culture supernatants was examined by Western blotting. LLC-MK2 cells were infected at an MOI of 0.05 and incubated in the absence or presence of trypsin (added every 24 h) for 4 days. Cell culture supernatant was analyzed by Western blotting with polyclonal serum directed against the cytoplasmic tail of F SeV (Fig. 3, upper right panel) . A band VOL. 85, 2011 SENDAI VIRUS ENCODING F PROTEIN CLEAVAGE MUTANTS 2773 representing wild-type F H was not observed in the absence of trypsin (Fig. 3, upper left panel) , reflecting the inability of SeV-F H to grow in the absence of trypsin (Fig. 2) . In contrast, the single-cleavage-site mutant Fc was present in uncleaved F 0 and cleaved F 1 forms in a ratio of 34%/66%, as determined by densitometry. Faint bands representing the F 0 precursor were seen for the double-cleavage-site mutants F117 and F130 in the absence of trypsin (Fig. 3, upper left panel) . In contrast, prominent bands representing partially cleaved intermediates (F 1 ϩ) were observed for both F117 and F130, which result from cleavage at site I but not at site II (16, 39) . The presence of cleavage intermediates was confirmed by the use of a polyclonal serum (Fig. 3, ␣F_104-117 ), which recognizes amino acids 104 to 117 of F RSV (an epitope included in the intervening region between the two cleavage sites that is also present in the F117 and F130 mutant proteins). The difference in migration between intermediate cleavage products for F117 and F130 may reflect differential glycosylation of pep27 since F117 contains two potential N-glycosylation sites within pep27, whereas F130 possesses three potential sites (Fig. 1A) . It has previously been estimated that at least two of the three sites are N-glycosylated for F RSV (52) . Indeed, the presence of an additional band for F130 F 1 ϩ that migrates with the same rate as F117 F 1 ϩ (Fig. 3 , upper left panel) may result from variable glycosylation of pep27. The proportion of fully cleaved F 1 protein was approximately the same for single-cleavage-site mutant Fc (66%) as double-cleavage-site mutants F117 (64%) and F130 (66%), suggesting that the insertion of a second, upstream cleavage site does not significantly affect cleavage of site II. In the presence of trypsin, the F proteins of all rSeV were completely cleaved to F 1 (Fig. 3, upper right panel) . Completion of cleavage of F117 and F130 at both sites was confirmed by loss of reactivity with the F RSV (104-117) serum ( Residues from F RSV that were inserted into the F SeV backbone to produce cleavage mutants are shown in red. The numbering assigned to F SeV mutants produced by mutation of Fc refers to the last residue of F RSV inserted, excluding cleavage site II. Recombinant Sendai virus expressing the F protein mutants was rescued by cotransfection of BSR-T7/5 cells with the FL5 plasmid containing the complete SeV cDNA and pTM1 plasmids encoding SeV N, P, and L genes. Rescued virus was subsequently passaged three times in embryonated chicken eggs. Titration of the allantoic fluid revealed that double-cleavage-site viruses were obtained at lower titers (FFU/ml) than single-cleavage-site viruses (SeV-F H titer, 5 ϫ 10 11 ; SeV-Fc, 9 ϫ 10 11 ; SeV-F117, 9 ϫ 10 10 ; SeV-F130, 5 ϫ 10 10 ). Allantoic fluid from the third passage in eggs was clarified and centrifuged through a 25% glycerol cushion, and equivalent titers of SeV-F H , SeV-Fc, SeV-F117, and SeV-F130 viruses were analyzed on a 10% SDS-PAGE gel stained with Coomassie blue (B) or by Western blotting (C) using the polyclonal rabbit antiserum that recognizes the cytoplasmic tail of F SeV . P, phosphoprotein; HN, hemagglutinin-neuraminidase; N, nucleoprotein; M, matrix protein.
creased virus titers seen at 33°C (Table 1) , it was hypothesized that double-cleavage-site mutants may have decreased thermostability. rSeV were purified from the allantoic fluid of embryonated eggs by sucrose gradient centrifugation and preincubated at 37°C for 2, 4, or 6 h. Heat-treated rSeV were subsequently tested for their ability to mediate hemolysis of guinea pig erythrocytes. rSeV was incubated at 33°C for 45 min with 0.5 ml of guinea pig erythrocytes (1%), and the extent of hemolysis was determined by measuring the optical density at 520 nm. Hemolysis results from changes in membrane permeability of erythrocytes following viral fusion and can therefore be used as a measure of virus-cell fusion. Hemolysis directed by the wt SeV-F H strain was significantly more resistant to heat treatment than the cleavage site mutant viruses (Fig. 4A) , retaining approximately 40% hemolytic activity even after 6 h of heat treatment, in agreement with previously published results for the fusion of SeV with liposomes (51) . In contrast, all cleavage site mutants were more readily inactivated by heat treatment. In particular, hemolysis directed by the doublecleavage-site mutant SeV-F130 strain, which contains the complete pep27 region of F RSV , was reduced to approximately 20% following just 4 h of incubation at 37°C. We subsequently tested the ability of heat-treated virus obtained from cell culture supernatants to infect LLC-MK2 cells. As shown in Fig.  4B , the titer of heat-inactivated viruses reflects the hemolysis results since wt SeV-F H was more resistant to heat treatment than the cleavage site mutants. Following 6 h of incubation at 37°C, the titer of wt SeV-F H virus remained approximately 2 logarithms higher than that of the cleavage site mutant viruses, with SeV-F130 displaying the lowest titer following heat treatment. Thus, insertion of one or both F RSV cleavage sites in F SeV leads to reduced thermostability since cleavage site mutants display reduced hemolytic activity and replicate to lower titers than wt SeV-F H following heat treatment. Moreover, the double-cleavage-site F130 mutant that contains the complete pep27 region, and thus most closely resembles F RSV , was the least thermostable virus. of cleavage site mutant viruses, LLC-MK2 cells grown in microchamber culture slides were infected at an MOI of 0.5 and incubated in the absence or presence of trypsin at 37°C. Cells were fixed at 30 h postinfection and stained with monoclonal antibody (MAb) GB5 that recognizes F SeV (Fig. 5A) . In order to quantitate the extent of syncytium formation by rSeV, the number of nuclei per syncytium was counted (Fig. 5B) . The presence of trypsin was essential for the formation of syncytia by SeV-F H , whereas all SeV cleavage mutant viruses formed syncytia in the absence of trypsin. Cleavage site mutant viruses also formed larger syncytia than SeV-F H . In particular, doublecleavage-site mutant viruses SeV-F117 and SeV-F130 formed syncytia that were approximately four times the size of the syncytia formed by SeV-F H virus in the presence of trypsin. Similar results were observed in BSR-T7/5 cells (data not shown).
Insertion of both RSV cleavage sites in the SeV fusion protein results in increased cell-cell fusion in recombinant SeV
Further quantitation of cell-cell fusion by recombinant viruses was carried out by analysis of cell content mixing using a luciferase reporter gene assay. BSR-T7/5 cells were infected with rSeV (MOI of 5) and subsequently mixed (14 h postinfection) with LLC-MK2 cells, which had been previously transfected with a plasmid encoding the luciferase gene (pTM1-Luc). The two populations of cells were left to fuse for 3 h at 37°C (Fig. 6A) or 33°C (Fig. 6B) trypsin. The results are expressed as a percentage of wild-type fusion (fusion of SeV-F H in the presence of trypsin). Cell-cell fusion mediated by the single-cleavage-site SeV-Fc mutant virus was not significantly increased with respect to wt SeV-F H at either 33°C or 37°C (Fig. 5) . In contrast, double-cleavage-site mutants SeV-F117 and SeV-F130 displayed increased cell-cell fusion, particularly at 33°C, with SeV-F117 producing the highest level of cell-cell fusion (approximately 3.5 times the level of wt cell fusion at 33°C). The increased titers seen for doublecleavage-site mutant viruses, particularly at 33°C (Fig. 2 and Table 1 ), may reflect increased cell-cell spread ( Fig. 5 and 6 ). In summary, insertion of double F RSV cleavage sites in F SeV leads to an increase in both syncytia size and the extent of cell content mixing.
Infection by double-cleavage-site rSeV mutants is less dependent on sialic acid receptor recognition. It has previously been reported that RSV infection can occur in the absence of the attachment protein (21) . It was therefore of interest to examine the dependency of recombinant Sendai viruses expressing cleavage site mutant proteins on sialic acid recognition by HN for infection. Two alternative approaches were employed to address this question.
In the first approach, LLC-MK2 cells growing in microchamber culture slides were treated with 120 mU of NA for 90 min at 37°C. Cells were subsequently infected with rSeV at an MOI of 1 and incubated in the absence of trypsin. The extent of infection was revealed by immunofluorescence of fixed cells with MAb GB5 at 20 h postinfection. The level of infection in response to neuraminidase treatment was determined by counting the number of infected cells. As shown in Fig. 7A , both single-cleavage-site viruses SeV-F H and SeV-Fc failed to produce significant infection in cells pretreated with neuraminidase. In contrast, double-cleavage-site mutant viruses SeV-F117 and SeV-F130 retained the ability to infect neuraminidase-treated cells, producing approximately 40% infection following neuraminidase treatment, compared to approximately 10% infection produced by single-cleavage-site mutants (Fig. 7B) . Similar results were seen when cells were incubated at 33°C (results not shown).
In the second approach, we infected a CHO cell line (Lec2) that is defective in sialic acid expression (45) . Lec2 cells are a derivative of Pro-5 cells and display a 90% reduction in the sialylation of glycoproteins due to defective transport of CMPsialic acid into the trans-Golgi compartment (11, 46) . Lec2 and Pro-5 cells were infected in microchamber culture slides at an MOI of 1 and subjected to immunofluorescence staining at 20 h postinfection. Whereas the single-cleavage-site viruses SeV-F H and SeV-Fc were unable to produce significant infection of Lec-2 cells, both double-cleavage-site viruses SeV-F117 and SeV-F130 were able to infect Lec2 cells, albeit at a reduced level compared to the level of infection observed in Pro-5 cells (Fig. 8A) . Syncytium formation was not observed in Lec2 cells, which may reflect the lower level of infection by F117 and F130 in this cell type. In order to quantify these results, an ELISA was carried out on infected Pro-5 and Lec2 cells at 20 h postinfection using the MAb GB5 directed against SeV F protein (Fig. 8B) . Single cleavage mutants produced only a low level of infection in Lec2 cells (approximately 4% the level of infection of wt Pro-5 cells), which probably reflects the background level of sialic acid expression in Lec2 cells (46) . However, double cleavage mutants SeV-F117 and SeV-F130 produced a higher level of infection in Lec2 cells (26% and 28%, respectively). Thus, while infection by double-cleavagesite mutants is enhanced by conditions that favor an interaction between HN and sialic acid, the presence of two cleavage sites reduces dependency on the HN protein for infection.
DISCUSSION
RSV is unique among paramyxoviruses since the RSV fusion protein (F RSV ) contains two multibasic cleavage sites and is able to fuse with target cell membranes in the absence of a separate attachment protein. It has previously been reported that insertion of both multibasic F RSV cleavage sites in the SeV fusion protein (F SeV ) leads to enhanced cell-cell fusion and decreased dependence on the attachment HN protein for syncytium formation in transfected cells (38) . We have extended this study to recombinant SeV (rSeV) that express either wildtype F protein (F H ) or F protein cleavage mutants containing F RSV cleavage site II (Fc) or both F RSV cleavage sites I and II and a partial or complete intervening pep27 sequence (Fig. 1A,  F117 and F130 ). The presence of both F RSV cleavage sites was found to increase the fusogenicity of rSeV (Fig. 5 and 6 ) and decrease the dependency on a separate receptor binding protein for infection by rSeV ( Fig. 7 and 8) , thereby mimicking the Cleavage site mutants, in particular, the double-cleavagesite mutant F130, were found to be less thermostable than wt SeV-F H virus (Fig. 4) . Previous studies have reported that mutations in the parainfluenza virus type 5 (PIV5) F protein (W3A strain) that result in hyperfusogenicity and HN-independent syncytium formation (19) act by destabilizing the prefusion conformation of the F protein (37, 41, 50) . Such destabilizing mutations may lower the activation energy required to trigger the F protein for fusion, thus reducing dependency on the HN protein for fusion (8, 37) . Similarly, the presence of double cleavage sites may reduce the thermostability of the F protein, thereby facilitating F activation for fusion by lowering the energy threshold required to trigger conformational changes involved in fusion. Indeed, our results indicated that the least thermostable mutant, SeV-F130, displayed the greatest ability to infect cells in an HN-independent manner. However, there was no strict correlation between thermostability (Fig. 4) and HN independence for infection since the singlecleavage-site mutant Fc was less thermostable than the wild type but still required sialic acid receptors for infection ( Fig. 7  and 8 ).
Destabilizing mutations that result in increased cell-cell fusion of the MLV Env glycoprotein were previously shown to be disadvantageous for virus growth (29) . In contrast, hyperfusogenic double-cleavage-site mutant rSeV were able to infect cells devoid of sialic acid receptors, reproducing the ability of recombinant RSV expressing the F protein in the absence of other cell surface glycoproteins to fuse and infect cells (21, 47, 48) . The infectivity of recombinant RSV that lacks attachment G protein expression suggests that the RSV F protein alone is capable of binding to target cells in order to mediate fusion. It has been shown that F RSV binds to cell surface glycosaminoglycans (GAGs), although less efficiently than the attachment G glycoprotein (14, 20, 48) . Indeed, infection by recombinant RSV is enhanced approximately 3-fold by the presence of the G protein (47) . Similarly, infection by the double-cleavage-site rSeV mutants was enhanced by the presence of sialic acid receptors on target cells ( Fig. 7 and 8) . While the precise region of the F protein involved in the interaction with GAGs has not been mapped, a heparin-binding peptide corresponding to F RSV cleavage site II and part of the fusion peptide was able to inhibit both attachment and infection by RSV (9) , suggesting that the cleavage site II region of F RSV interacts with cell surface GAGs.
The furin-dependent cleavage site of a number of other viruses has also been suggested as a candidate heparan sulfate binding domain (10, 24, 36) . In particular, binding of Sindbis virus E2 protein to heparan sulfate correlates with the amount of uncleaved E2 present in the virion (24) . The presence of partially cleaved F protein from rSeV grown in the absence of trypsin indicates that the uncleaved, multibasic cleavage site II is present on approximately one-third of F molecules (Fig. 3) and would thus be available to bind to cell surface GAGs. Binding of cleavage site II to GAGs may promote fusion in the absence of a separate attachment protein by facilitating either completion of cleavage of all F molecules within the trimer by furin present at the plasma membrane (49) or the fusion of adjacent, F protein trimers that are already fully cleaved. How- ever, only double-cleavage-site rSeV mutants were able to infect sialic acid-deficient cells, suggesting that furin cleavage site I is also involved in the binding to GAGs and/or the triggering of fusion.
While mutations of F RSV cleavage site I and the intervening peptide in the context of recombinant bovine RSV (rBRSV) affect syncytium formation, they still permit virus replication in cell culture (53) . Given the potential role of double cleavage in attachment protein-independent fusion, it would be of interest to investigate the phenotype of F RSV cleavage site mutations in the context of a recombinant RSV lacking the attachment G protein.
In addition to the role of HN in binding to target cell receptors, it is also possible that the HN protein played a role in the stabilization of the rSeV cleavage mutants by interacting with mutant F proteins. In order to confirm whether double cleavage of F SeV permits infection in the complete absence of the HN protein, we are currently investigating if rSeV expressing the double-cleavage-site F protein mutants can be rescued in the absence of the HN attachment protein or in the presence of an HN protein with altered receptor binding properties. rSeV in which both the SeV F and HN proteins were replaced by RSV F protein has previously been rescued (54) . Therefore, although other regions of F RSV could also contribute to attachment protein-independent fusion, the results presented here indicate that the double-cleavage region of F RSV may play a crucial role in the unique ability of RSV to fuse and infect cells in the absence of a separate attachment protein.
